Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration

Neurobiology of Aging

Volumn 35, Issue 6, 2014, Pages 1473-1482

  McMillan, Corey T ^a   Toledo, Jon B ^a   Avants, Brian B ^a   Cook, Philip A ^a   Wood, Elisabeth M ^a   Suh, Eunran ^a   Irwin, David J ^a   Powers, John ^a   Olm, Christopher ^a   Elman, Lauren ^a   McCluskey, Leo ^a   Schellenberg, Gerard D ^a   Lee, Virginia M Y ^a   Trojanowski, John Q ^a   Van Deerlin, Vivianna M ^a   Grossman, Murray ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Biomarkers; Frontotemporal lobar degeneration; Genetics; Neuroimaging

Indexed keywords

ADULT; ARCUATE FASCICULUS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION TENSOR IMAGING; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GRAY MATTER; HOMOZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROANATOMY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; BRAIN; GENETICS; MUTATION; PATHOLOGY; RISK;

DNA BINDING PROTEIN; MAPT PROTEIN, HUMAN; MOBP PROTEIN, HUMAN; MYELIN PROTEIN; PROTEIN TDP-43; SORTILIN; TAU PROTEIN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; BRAIN; DIFFUSION TENSOR IMAGING; DNA-BINDING PROTEINS; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; MUTATION; MYELIN PROTEINS; NEUROIMAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TAU PROTEINS;

EID: 84903368483     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.11.029     Document Type: Article

References (54)

1. Ahmed Z., Mackenzie I.R.A., Hutton M.L., Dickson D.W. Progranulin in frontotemporal lobar degeneration and neuroinflammation. J.Neuroinflamm. 2007, 4:7.
2. Avants B., Dhillon P., Kandel B.M., Cook P.A., McMillan C.T., Grossman M., Gee J.C. Eigenanatomy improves detection power for longitudinal cortical change. Med. Image Comput. Comput. Assist. Interv. 2012, 15:206-213.
3. Avants B.B., Cook P.A., Ungar L., Gee J.C., Grossman M. Dementia induces correlated reductions in white matter integrity and cortical thickness: a multivariate neuroimaging study with sparse canonical correlation analysis. NeuroImage 2010, 50:1004-1016.
4. Avants B.B., Tustison N.J., Song G., Cook P.A., Klein A., Gee J.C. Areproducible evaluation of ANTs similarity metric performance in brain image registration. NeuroImage 2011, 54:2033-2044.
5. Baker M., Litvan I., Houlden H., Adamson J., Dickson D., Perez-Tur J., Hardy J., Lynch T., Bigio E., Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 1999, 8:711-715.
6. Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., Snowden J., Adamson J., Sadovnick A.D., Rollinson S., Cannon A., Dwosh E., Neary D., Melquist S., Richardson A., Dickson D., Berger Z., Eriksen J., Robinson T., Zehr C., Dickey C.A., Crook R., McGowan E., Mann D., Boeve B., Feldman H., Hutton M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006, 442:916-919.
7. Borroni B., Alberici A., Premi E., Archetti S., Garibotto V., Agosti C., Gasparotti R., Di Luca M., Perani D., Padovani A. Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers. Rejuvenation Res. 2008, 11:585-595.
8. Boxer A.L., Gold M., Huey E., Gao F.-B., Burton E.A., Chow T., Kao A., Leavitt B.R., Lamb B., Grether M., Knopman D., Cairns N.J., Mackenzie I.R., Mitic L., Roberson E.D., Van Kammen D., Cantillon M., Zahs K., Salloway S., Morris J., Tong G., Feldman H., Fillit H., Dickinson S., Khachaturian Z., Sutherland M., Farese R., Miller B.L., Cummings J. Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development. Alzheimers Dement. 2013, 9:176-188.
9. Bozzali M., Battistoni V., Premi E., Alberici A., Giulietti G., Archetti S., Turla M., Gasparotti R., Cercignani M., Padovani A., Borroni B. Structural brain signature of FTLD driven by granulin mutation. J.Alzheimers Dis. 2013, 33:483-494.
10. Carrasquillo M.M., Nicholson A.M., Finch N., Gibbs J.R., Baker M., Rutherford N.J., Hunter T.A., DeJesus-Hernandez M., Bisceglio G.D., Mackenzie I.R., Singleton A., Cookson M.R., Crook J.E., Dillman A., Hernandez D., Petersen R.C., Graff-Radford N.R., Younkin S.G., Rademakers R. Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma. Am. J. Hum. Genet. 2010, 87:890-897.
11. Connelly S.J., Mukaetova-Ladinska E.B., Abdul-All Z., Alves da Silva J., Brayne C., Honer W.G., Mann D.M.A. Synaptic changes in frontotemporal lobar degeneration: correlation with MAPT haplotype and APOE genotype. Neuropathol. Appl. Neurobiol. 2011, 37:366-380.
12. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.-Y.R., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
13. Di Maria E., Tabaton M., Vigo T., Abbruzzese G., Bellone E., Donati C., Frasson E., Marchese R., Montagna P., Munoz D.G., Pramstaller P.P., Zanusso G., Ajmar F., Mandich P. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann. Neurol. 2000, 47:374-377.
14. Dickson D.W., Ahmed Z., Algom A.A., Tsuboi Y., Josephs K.A. Neuropathology of variants of progressive supranuclear palsy. Curr. Opin. Neurol. 2010, 23:394-400.
15. Forman M.S., Zhukareva V., Bergeron C., Chin S.S.-M., Grossman M., Clark C., Lee V.M.-Y., Trojanowski J.Q. Signature tau neuropathology in gray and white matter of corticobasal degeneration. Am. J. Pathol. 2002, 160:2045-2053.
16. Gass J., Cannon A., Mackenzie I.R., Boeve B., Baker M., Adamson J., Crook R., Melquist S., Kuntz K., Petersen R., Josephs K., Pickering-Brown S.M., Graff-Radford N., Uitti R., Dickson D., Wszolek Z., Gonzalez J., Beach T.G., Bigio E., Johnson N., Weintraub S., Mesulam M., White C.L., Woodruff B., Caselli R., Hsiung G.-Y., Feldman H., Knopman D., Hutton M., Rademakers R. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum. Mol. Genet. 2006, 15:2988-3001.
17. Geser F., Martinez-Lage M., Robinson J., Uryu K., Neumann M., Brandmeir N.J., Xie S.X., Kwong L.K., Elman L., McCluskey L., Clark C.M., Malunda J., Miller B.L., Zimmerman E.A., Qian J., Van Deerlin V., Grossman M., Lee V.M.-Y., Trojanowski J.Q. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch. Neurol. 2009, 66:180-189.
18. Geser F., Prvulovic D., O'Dwyer L., Hardiman O., Bede P., Bokde A.L.W., Trojanowski J.Q., Hampel H. On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia. Prog. Neurobiol. 2011, 95:649-662.
19. Grossman M. Primary progressive aphasia: clinicopathological correlations. Nat. Rev. Neurol. 2010, 6:88-97.
20. Höglinger G.U., Melhem N.M., Dickson D.W., Sleiman P.M.A., Wang L.-S., Klei L., Rademakers R., de Silva R., Litvan I., Riley D.E., van Swieten J.C., Heutink P., Wszolek Z.K., Uitti R.J., Vandrovcova J., Hurtig H.I., Gross R.G., Maetzler W., Goldwurm S., Tolosa E., Borroni B., Pastor P., Cantwell L.B., Han M.R., Dillman A., van der Brug M.P., Gibbs J.R., Cookson M.R., Hernandez D.G., Singleton A.B., Farrer M.J., Yu C.-E., Golbe L.I., Revesz T., Hardy J., Lees A.J., Devlin B., Hakonarson H., Müller U., Schellenberg G.D. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat. Genet. 2011, 43:699-705. PSP Genetics Study Group.
21. Hsiung G.-Y.R., Fok A., Feldman H.H., Rademakers R., Mackenzie I.R.A. rs5848 polymorphism and serum progranulin level. J.Neurol. Sci. 2011, 300:28-32.
22. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., Heutink P. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705.
23. Irwin D., Lippa C.F., Rosso A. Progranulin (PGRN) expression in ALS: an immunohistochemical study. J.Neurol. Sci. 2009, 276:9-13.
24. Irwin D.J., Cohen T.J., Grossman M., Arnold S.E., Xie S.X., Lee V.M.-Y., Trojanowski J.Q. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain 2012, 135:807-818.
25. Irwin D.J., McMillan C.T., Toledo J.B., Arnold S.E., Shaw L.M., Wang L.-S., Van Deerlin V., Lee V.M.-Y., Trojanowski J.Q., Grossman M. Comparison of cerebrospinal fluid levels of tau and Aβ 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms. Arch. Neurol. 2012, 69:1018-1025.
26. Jahanshad N., Rajagopalan P., Hua X., Hibar D.P., Nir T.M., Toga A.W., Jack C.R., Saykin A.J., Green R.C., Weiner M.W., Medland S.E., Montgomery G.W., Hansell N.K., McMahon K.L., de Zubicaray G.I., Martin N.G., Wright M.J., Thompson P.M. Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity. Proc. Natl. Acad. Sci. U.S.A 2013, 110:4768-4773. Alzheimer's Disease Neuroimaging Initiative.
27. Kelley B.J., Haidar W., Boeve B.F., Baker M., Graff-Radford N.R., Krefft T., Frank A.R., Jack C.R., Shiung M., Knopman D.S., Josephs K.A., Parashos S.A., Rademakers R., Hutton M., Pickering-Brown S., Adamson J., Kuntz K.M., Dickson D.W., Parisi J.E., Smith G.E., Ivnik R.J., Petersen R.C. Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol. Aging 2009, 30:739-751.
28. Laws S.M., Perneczky R., Drzezga A., Diehl-Schmid J., Ibach B., Bäuml J., Eisele T., Förstl H., Kurz A., Riemenschneider M. Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia. Am. J. Psychiatry 2007, 164:1577-1584.
29. Lippa C.F., Rosso A.L., Stutzbach L.D., Neumann M., Lee V.M.-Y., Trojanowski J.Q. Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome. Arch. Neurol. 2009, 66:1483-1488.
30. Liu Q.-Y., Yu J.-T., Miao D., Ma X.-Y., Wang H.-F., Wang W., Tan L. An exploratory study on STX6, MOBP, MAPT, and EIF2AK3 and late-onset Alzheimer's disease. Neurobiol. Aging 2013, 34:1519.e13-1519.e17.
31. Mackenzie I.R.A., Neumann M., Bigio E.H., Cairns N.J., Alafuzoff I., Kril J., Kovacs G.G., Ghetti B., Halliday G., Holm I.E., Ince P.G., Kamphorst W., Revesz T., Rozemuller A.J.M., Kumar-Singh S., Akiyama H., Baborie A., Spina S., Dickson D.W., Trojanowski J.Q., Mann D.M.A. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010, 119:1-4.
32. McMillan C.T., Irwin D.J., Avants B., Powers J., Cook P., Toledo J.B., Wood E.M., Van Deerlin V.M., Lee C.M.-Y., Trojanowski J.Q., Grossman M. White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration. J.Neurol. Neurosurg. Psychiatry 2013, 84:949-955.
33. Montague P., McCallion A.S., Davies R.W., Griffiths I.R. Myelin-associated oligodendrocytic basic protein: a family of abundant CNS myelin proteins in search of a function. Dev. Neurosci. 2006, 28:479-487.
34. Neumann M., Kwong L.K., Lee E.B., Kremmer E., Flatley A., Xu Y., Forman M.S., Troost D., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 2009, 117:137-149.
35. Otvos L., Feiner L., Lang E., Szendrei G.I., Goedert M., Lee V.M. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J.Neurosci. Res. 1994, 39:669-673.
36. Potkin S.G., Turner J.A., Guffanti G., Lakatos A., Torri F., Keator D.B., Macciardi F. Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations. Cogn. Neuropsychiatry 2009, 14:391-418.
37. Rademakers R., Eriksen J.L., Baker M., Robinson T., Ahmed Z., Lincoln S.J., Finch N., Rutherford N.J., Crook R.J., Josephs K.A., Boeve B.F., Knopman D.S., Petersen R.C., Parisi J.E., Caselli R.J., Wszolek Z.K., Uitti R.J., Feldman H., Hutton M.L., Mackenzie I.R., Graff-Radford N.R., Dickson D.W. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum. Mol. Genet. 2008, 17:3631-3642.
38. Rademakers R., Melquist S., Cruts M., Theuns J., Del-Favero J., Poorkaj P., Baker M., Sleegers K., Crook R., De Pooter T., Bel Kacem S., Adamson J., Van den Bossche D., Van den Broeck M., Gass J., Corsmit E., De Rijk P., Thomas N., Engelborghs S., Heckman M., Litvan I., Crook J., De Deyn P.P., Dickson D., Schellenberg G.D., Van Broeckhoven C., Hutton M.L. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum. Mol. Genet. 2005, 14:3281-3292.
39. Renton A.E., Majounie E., Waite A., Simón-Sánchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A., Scholz S.W., Duckworth J., Ding J., Harmer D.W., Hernandez D.G., Johnson J.O., Mok K., Ryten M., Trabzuni D., Guerreiro R.J., Orrell R.W., Neal J., Murray A., Pearson J., Jansen I.E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J.B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M.A., Peuralinna T., Jansson L., Isoviita V.-M., Kaivorinne A.-L., Hölttä-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chiò A., Restagno G., Borghero G., Sabatelli M., Heckerman D., Rogaeva E., Zinman L., Rothstein J.D., Sendtner M., Drepper C., Eichler E.E., Alkan C., Abdullaev Z., Pack S.D., Dutra A., Pak E., Hardy J., Singleton A., Williams N.M., Heutink P., Pickering-Brown S., Morris H.R., Tienari P.J., Traynor B.J. Ahexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268. ITALSGEN Consortium.
40. Rohrer J.D., Ridgway G.R., Modat M., Ourselin S., Mead S., Fox N.C., Rossor M.N., Warren J.D. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. NeuroImage 2010, 53:1070-1076.
41. Rollinson S., Rohrer J.D., van der Zee J., Sleegers K., Mead S., Engelborghs S., Collinge J., De Deyn P.P., Mann D.M.A., Van Broeckhoven C., Pickering-Brown S.M. No association of PGRN 3'UTR rs5848 in frontotemporal lobar degeneration. Neurobiol. Aging 2011, 32:754-755.
42. Seltman R.E., Matthews B.R. Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management. CNS Drugs 2012, 26:841-870.
43. Shen L., Kim S., Risacher S.L., Nho K., Swaminathan S., West J.D., Foroud T., Pankratz N., Moore J.H., Sloan C.D., Huentelman M.J., Craig D.W., Dechairo B.M., Potkin S.G., Jack C.R., Weiner M.W., Saykin A.J. Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: a study of the ADNI cohort. NeuroImage 2010, 53:1051-1063. Alzheimer's Disease Neuroimaging Initiative.
44. Simón-Sánchez J., Seelaar H., Bochdanovits Z., Deeg D.J.H., van Swieten J.C., Heutink P. Variation at GRN 3'-UTR rs5848 is not associated with a risk of frontotemporal lobar degeneration in Dutch population. PLoS One 2009, 4:e7494.
45. Stein J.L., Hua X., Lee S., Ho A.J., Leow A.D., Toga A.W., Saykin A.J., Shen L., Foroud T., Pankratz N., Huentelman M.J., Craig D.W., Gerber J.D., Allen A.N., Corneveaux J.J., Dechairo B.M., Potkin S.G., Weiner M.W., Thompson P. Voxelwise genome-wide association study (vGWAS). NeuroImage 2010, 53:1160-1174. Alzheimer's Disease Neuroimaging Initiative.
46. Van Deerlin V.M., Sleiman P.M.A., Martinez-Lage M., Chen-Plotkin A., Wang L.-S., Graff-Radford N.R., Dickson D.W., Rademakers R., Boeve B.F., Grossman M., Arnold S.E., Mann D.M.A., Pickering-Brown S.M., Seelaar H., Heutink P., van Swieten J.C., Murrell J.R., Ghetti B., Spina S., Grafman J., Hodges J., Spillantini M.G., Gilman S., Lieberman A.P., Kaye J.A., Woltjer R.L., Bigio E.H., Mesulam M., Al-Sarraj S., Troakes C., Rosenberg R.N., White C.L., Ferrer I., Lladó A., Neumann M., Kretzschmar H.A., Hulette C.M., Welsh-Bohmer K.A., Miller B.L., Alzualde A., Lopez de Munain A., McKee A.C., Gearing M., Levey A.I., Lah J.J., Hardy J., Rohrer J.D., Lashley T., Mackenzie I.R.A., Feldman H.H., Hamilton R.L., Dekosky S.T., van der Zee J., Kumar-Singh S., Van Broeckhoven C., Mayeux R., Vonsattel J.P.G., Troncoso J.C., Kril J.J., Kwok J.B.J., Halliday G.M., Bird T.D., Ince P.G., Shaw P.J., Cairns N.J., Morris J.C., McLean C.A., DeCarli C., Ellis W.G., Freeman S.H., Frosch M.P., Growdon J.H., Perl D.P., Sano M., Bennett D.A., Schneider J.A., Beach T.G., Reiman E.M., Woodruff B.K., Cummings J., Vinters H.V., Miller C.A., Chui H.C., Alafuzoff I., Hartikainen P., Seilhean D., Galasko D., Masliah E., Cotman C.W., Tuñón M.T., Martínez M.C.C., Munoz D.G., Carroll S.L., Marson D., Riederer P.F., Bogdanovic N., Schellenberg G.D., Hakonarson H., Trojanowski J.Q., Lee V.M. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat. Genet. 2010, 42:234-239.
47. Whitwell J.L., Avula R., Master A., Vemuri P., Senjem M.L., Jones D.T., Jack C.R., Josephs K.A. Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study. Parkinsonism Relat. Disord. 2011, 17:599-605.
48. Whitwell J.L., Jack C.R., Parisi J.E., Knopman D.S., Boeve B.F., Petersen R.C., Dickson D.W., Josephs K.A. Imaging signatures of molecular pathology in behavioral variant frontotemporal dementia. J.Mol. Neurosci. 2011, 45:372-378.
49. Whitwell J.L., Jack C.R., Senjem M.L., Parisi J.E., Boeve B.F., Knopman D.S., Dickson D.W., Petersen R.C., Josephs K.A. MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration. Neurodegener. Dis. 2009, 6:106-117.
50. Whitwell J.L., Master A.V., Avula R., Kantarci K., Eggers S.D., Edmonson H.A., Jack C.R., Josephs K.A. Clinical correlates of white matter tract degeneration in progressive supranuclear palsy. Arch. Neurol. 2011, 68:753-760.
51. Whitwell J.L., Weigand S.D., Boeve B.F., Senjem M.L., Gunter J.L., DeJesus-Hernandez M., Rutherford N.J., Baker M., Knopman D.S., Wszolek Z.K., Parisi J.E., Dickson D.W., Petersen R.C., Rademakers R., Jack C.R., Josephs K.A. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain 2012, 135:794-806.
52. Wider C., Ross O.A., Nishioka K., Heckman M.G., Vilariño-Güell C., Jasinska-Myga B., Erketin-Taner N., Rademakers R., Graff-Radford N.R., Mash D.C., Papapetropoulos S., Duara R., Uchikado H., Wszolek Z.K., Farrer M.J., Dickson D.W. An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology. J.Neurol. Neurosurg. Psychiatry 2012, 83:424-429.
53. Wood E.M., Falcone D., Suh E., Irwin D.J., Chen-Plotkin A.S., Lee E.B., Xie S.X., Van Deerlin V.M., Grossman M. Development and validation of pedigree classification criteria for frontotemporal lobar degeneration. JAMA Neurol. 2013, 70:1411-1417.
54. Yamamoto Y., Yoshikawa H., Nagano S., Kondoh G., Sadahiro S., Gotow T., Yanagihara T., Sakoda S. Myelin-associated oligodendrocytic basic protein is essential for normal arrangement of the radial component in central nervous system myelin. Eur. J. Neurosci. 1999, 11:847-855.